Semanteon Capital Management LP Makes New Investment in Transcat, Inc. (NASDAQ:TRNS)

Semanteon Capital Management LP purchased a new position in Transcat, Inc. (NASDAQ:TRNS) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 7,107 shares of the scientific and technical instruments company’s stock, valued at approximately $777,000. Semanteon Capital Management LP owned approximately 0.08% of Transcat as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the business. State Board of Administration of Florida Retirement System acquired a new position in shares of Transcat during the third quarter worth $207,000. Arizona State Retirement System acquired a new position in shares of Transcat during the third quarter worth $213,000. James Investment Research Inc. acquired a new position in shares of Transcat during the third quarter worth $221,000. Quantbot Technologies LP grew its stake in shares of Transcat by 118.2% during the third quarter. Quantbot Technologies LP now owns 2,370 shares of the scientific and technical instruments company’s stock worth $232,000 after purchasing an additional 1,284 shares in the last quarter. Finally, Diversified Trust Co grew its stake in shares of Transcat by 4.3% during the fourth quarter. Diversified Trust Co now owns 2,435 shares of the scientific and technical instruments company’s stock worth $266,000 after purchasing an additional 100 shares in the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.

Analyst Ratings Changes

TRNS has been the subject of several research analyst reports. Oppenheimer restated an “outperform” rating and issued a $125.00 price objective (up previously from $120.00) on shares of Transcat in a research note on Thursday, April 18th. TheStreet upgraded shares of Transcat from a “c+” rating to a “b” rating in a research note on Wednesday, January 31st. Finally, HC Wainwright restated a “buy” rating and issued a $124.00 price objective on shares of Transcat in a research note on Tuesday, April 16th.

Transcat Stock Performance

Shares of NASDAQ:TRNS traded down $0.01 on Friday, reaching $109.83. The company’s stock had a trading volume of 60,743 shares, compared to its average volume of 38,680. The stock’s 50-day moving average is $108.73 and its two-hundred day moving average is $102.61. Transcat, Inc. has a 52-week low of $74.89 and a 52-week high of $116.19. The company has a debt-to-equity ratio of 0.01, a current ratio of 3.37 and a quick ratio of 2.81. The stock has a market capitalization of $969.80 million, a P/E ratio of 84.49 and a beta of 0.59.

Transcat (NASDAQ:TRNS) last posted its quarterly earnings results on Monday, January 29th. The scientific and technical instruments company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.03. The firm had revenue of $65.17 million during the quarter, compared to analysts’ expectations of $63.36 million. Transcat had a net margin of 4.16% and a return on equity of 9.32%. As a group, sell-side analysts forecast that Transcat, Inc. will post 1.34 EPS for the current year.

Insider Buying and Selling

In related news, CEO Lee D. Rudow sold 2,373 shares of the stock in a transaction dated Saturday, March 30th. The shares were sold at an average price of $111.43, for a total transaction of $264,423.39. Following the completion of the transaction, the chief executive officer now directly owns 103,688 shares of the company’s stock, valued at $11,553,953.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CEO Lee D. Rudow sold 5,000 shares of Transcat stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $111.30, for a total transaction of $556,500.00. Following the completion of the sale, the chief executive officer now directly owns 108,478 shares in the company, valued at approximately $12,073,601.40. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Lee D. Rudow sold 2,373 shares of the firm’s stock in a transaction that occurred on Saturday, March 30th. The stock was sold at an average price of $111.43, for a total transaction of $264,423.39. Following the transaction, the chief executive officer now directly owns 103,688 shares of the company’s stock, valued at $11,553,953.84. The disclosure for this sale can be found here. Insiders sold 8,073 shares of company stock valued at $900,023 over the last ninety days. Corporate insiders own 4.20% of the company’s stock.

Transcat Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.